Literature DB >> 31366236

Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.

Charles R Mackay1, Niels O S Camara2,3, Raphael J F Felizardo2,3,1, Danilo C de Almeida2,3, Rafael L Pereira4, Ingrid K M Watanabe2,3, Nayara T S Doimo5, Willian R Ribeiro6, Marcos A Cenedeze2, Meire I Hiyane3, Mariane T Amano3,5, Tárcio T Braga3, Caroline M Ferreira6, Raphael B Parmigiani7, Vinicius Andrade-Oliveira3, Rildo A Volpini8, Marco Aurélio R Vinolo9, Eliana Mariño1, Remy Robert1.   

Abstract

Butyrate is a short-chain fatty acid derived from the metabolism of indigestible carbohydrates by the gut microbiota. Butyrate contributes to gut homeostasis, but it may also control inflammatory responses and host physiology in other tissues. Butyrate inhibits histone deacetylases, thereby affecting gene transcription, and also signals through the metabolite-sensing G protein receptor (GPR)109a. We produced an mAb to mouse GPR109a and found high expression on podocytes in the kidney. Wild-type and Gpr109a-/- mice were induced to develop nephropathy by a single injection of Adriamycin and treated with sodium butyrate or high butyrate-releasing high-amylose maize starch diet. Butyrate improved proteinuria by preserving podocyte at glomerular basement membrane and attenuated glomerulosclerosis and tissue inflammation. This protective phenotype was associated with increased podocyte-related proteins and a normalized pattern of acetylation and methylation at promoter sites of genes essential for podocyte function. We found that GPR109a is expressed by podocytes, and the use of Gpr109a-/- mice showed that the protective effects of butyrate depended on GPR109a expression. A prebiotic diet that releases high amounts of butyrate also proved highly effective for protection against kidney disease. Butyrate and GPR109a play a role in the pathogenesis of kidney disease and provide one of the important molecular connections between diet, the gut microbiota, and kidney disease.-Felizardo, R. J. F., de Almeida, D. C., Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. S., Ribeiro, W. R., Cenedeze, M. A., Hiyane, M. I., Amano, M. T., Braga, T. T., Ferreira, C. M., Parmigiani, R. B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Mariño, E., Robert, R., Mackay, C. R., Camara, N. O. S. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.

Entities:  

Keywords:  ADR nephropathy; SCFA; glomerulopathy; podocyte

Mesh:

Substances:

Year:  2019        PMID: 31366236     DOI: 10.1096/fj.201901080R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  24 in total

1.  Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.

Authors:  Yan Jun Li; Xiaochen Chen; Tony K Kwan; Yik Wen Loh; Julian Singer; Yunzi Liu; Jin Ma; Jian Tan; Laurence Macia; Charles R Mackay; Steven J Chadban; Huiling Wu
Journal:  J Am Soc Nephrol       Date:  2020-05-01       Impact factor: 10.121

2.  Mathematical Modeling of the Gut-Bone Axis and Implications of Butyrate Treatment on Osteoimmunology.

Authors:  Mohammad Aminul Islam; Carley V Cook; Brenda J Smith; Ashlee N Ford Versypt
Journal:  Ind Eng Chem Res       Date:  2021-11-30       Impact factor: 3.720

3.  Renal Sensing of Bacterial Metabolites in the Gut-kidney Axis.

Authors:  Orestes Foresto-Neto; Bruno Ghirotto; Niels Olsen Saraiva Câmara
Journal:  Kidney360       Date:  2021-07-02

4.  Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lauren Pickel; Ioan-Andrei Iliuta; James Scholey; York Pei; Hoon-Ki Sung
Journal:  Adv Nutr       Date:  2021-11-10       Impact factor: 8.701

5.  Oral and intravenous iron treatment alter the gut microbiome differentially in dialysis patients.

Authors:  Huan Liu; Wenqi Wu; Yankun Luo
Journal:  Int Urol Nephrol       Date:  2022-09-27       Impact factor: 2.266

6.  Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.

Authors:  Chunying Wu; Zhida Chen; Linlin Zhang; Yeyan Zhu; Mokan Deng; Cailin Huang; Yuting Liu; Qing Zhu; Lei Wang
Journal:  Hypertens Res       Date:  2020-09-09       Impact factor: 3.872

Review 7.  Targeting immune cell metabolism in kidney diseases.

Authors:  Paulo José Basso; Vinicius Andrade-Oliveira; Niels Olsen Saraiva Câmara
Journal:  Nat Rev Nephrol       Date:  2021-04-07       Impact factor: 28.314

8.  Microbiota, Epigenetics, and Trained Immunity. Convergent Drivers and Mediators of the Asthma Trajectory from Pregnancy to Childhood.

Authors:  Susan V Lynch; Donata Vercelli
Journal:  Am J Respir Crit Care Med       Date:  2021-04-01       Impact factor: 21.405

Review 9.  Understudied G Protein-Coupled Receptors in the Kidney.

Authors:  Nathan A Zaidman; Jennifer L Pluznick
Journal:  Nephron       Date:  2021-07-14       Impact factor: 3.457

Review 10.  Significance of the Gut Microbiota in Acute Kidney Injury.

Authors:  Taku Kobayashi; Yasunori Iwata; Yusuke Nakade; Takashi Wada
Journal:  Toxins (Basel)       Date:  2021-05-22       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.